日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas

胶质母细胞瘤常氧和缺氧微环境中检查点标记物的差异表达

Stine Asferg Petterson, Mia Dahl Sørensen, Mark Burton, Mads Thomassen, Torben A Kruse, Signe Regner Michaelsen, Bjarne Winther Kristensen

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors

胶质母细胞瘤的手术切除可诱导复发性肿瘤中多效蛋白介导的胶质母细胞瘤干细胞自我更新

Arnon Møldrup Knudsen, Bo Halle, Oriane Cédile, Mark Burton, Christina Baun, Helge Thisgaard, Atul Anand, Christopher Hubert, Mads Thomassen, Signe Regner Michaelsen, Birgitte Brinkmann Olsen, Rikke Hedegaard Dahlrot, Rolf Bjerkvig, Justin Durla Lathia, Bjarne Winther Kristensen8

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

基于来自单一机构的连续非选择性患者的前瞻性队列,对接受标准疗法治疗的胶质母细胞瘤患者建立预后模型

Armita Armina Abedi, Kirsten Grunnet, Ib Jarle Christensen, Signe Regner Michaelsen, Aida Muhic, Søren Møller, Benedikte Hasselbalch, Hans Skovgaard Poulsen, Thomas Urup

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

血管紧张素原启动子甲基化预测复发性胶质母细胞瘤患者对贝伐单抗治疗的反应

Thomas Urup, Linn Gillberg, Katja Kaastrup, Maya Jeje Schuang Lü, Signe Regner Michaelsen, Vibeke Andrée Larsen, Ib Jarle Christensen, Helle Broholm, Ulrik Lassen, Kirsten Grønbaek, Hans Skovgaard Poulsen

Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B

通过抑制赖氨酸特异性组蛋白去甲基化酶 KDM2B 来靶向神经胶质瘤干细胞样细胞的存活和化学耐药性

Mikkel Staberg, Rikke Darling Rasmussen, Signe Regner Michaelsen, Henriette Pedersen, Kamilla Ellermann Jensen, Mette Villingshøj, Jane Skjoth-Rasmussen, Jannick Brennum, Kristoffer Vitting-Seerup, Hans Skovgaard Poulsen, Petra Hamerlik

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

贝伐单抗联合治疗对有反应和无反应的复发性胶质母细胞瘤患者引起的转录变化

Thomas Urup, Line Mærsk Staunstrup, Signe Regner Michaelsen, Kristoffer Vitting-Seerup, Marc Bennedbæk, Anders Toft, Lars Rønn Olsen, Lars Jønson, Shohreh Issazadeh-Navikas, Helle Broholm, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro

EGFR 和 Notch 联合抑制对胶质母细胞瘤细胞活力和胶质母细胞瘤诱导的内皮细胞发芽具有附加抑制作用

Mikkel Staberg #, Signe Regner Michaelsen #, Louise Stobbe Olsen, Mette Kjølhede Nedergaard, Mette Villingshøj, Marie-Thérése Stockhausen, Petra Hamerlik, Hans Skovgaard Poulsen

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

血管紧张素原和 HLA II 类预测复发性胶质母细胞瘤患者对贝伐单抗的反应

Thomas Urup, Signe Regner Michaelsen, Lars Rønn Olsen, Anders Toft, Ib Jarle Christensen, Kirsten Grunnet, Ole Winther, Helle Broholm, Michael Kosteljanetz, Shohreh Issazadeh-Navikas, Hans Skovgaard Poulsen, Ulrik Lassen

18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma

18F-FET microPET 和 microMRI 用于人类胶质母细胞瘤原位小鼠模型中抗 VEGF 和抗 PlGF 反应评估

Mette Kjoelhede Nedergaard, Signe Regner Michaelsen, Thomas Urup, Helle Broholm, Henrik El Ali, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Andreas Kjaer, Ulrik Lassen